Merck Serono competitive analysis

Explore patent oppositions filed by Merck Serono against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Unitary Combination Of Fsh And HcgFERRINGMay 5, 2020
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRINGDec 22, 2017
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRINGMay 15, 2017
Tumor Therapy With An Anti-Vegf AntibodyF HOFFMANN LA ROCHEMar 9, 2016
Method For Treating Joint DamageBIOGEN IDECJul 21, 2015

Explore Merck Serono's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Oct 16, 2024Cladribine Regimen For Treating Multiple Sclerosis1
Jan 17, 2018Cladribine Regimen For Treating Multiple Sclerosis1
Dec 13, 2017The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein Production1
Nov 9, 2016Use Of Il-6-Type Cytokines For Maturation Of Oocytes1

Latest PTAB cases involving Merck Serono

Discover the latest PTAB cases involving Merck Serono, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 29, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merck Serono

IPR2023-00480Jan 23, 2023HOPEWELL PHARMA VENTURESMERCK SERONOFinal Written Decision
IPR2023-00481Jan 23, 2023HOPEWELL PHARMA VENTURESMERCK SERONOFinal Written Decision
IPR2023-00049Oct 14, 2022TWI PHARMACEUTICALSMERCK SERONOFinal Written Decision
IPR2023-00050Oct 14, 2022TWI PHARMACEUTICALSMERCK SERONOFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Merck Serono with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERCK SERONO54 - 4
FERRING822 - -
F HOFFMANN LA ROCHE34257 - -
HOPEWELL PHARMA VENTURES - - 3 -